Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple energy tricks may ease COPD fatigue in daily life

NCT ID NCT07581132

Symptom relief Sponsor: Akdeniz University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 2 times

Summary

This study tests whether teaching COPD patients structured energy conservation techniques—like planning activities, using proper body mechanics, and breathing exercises—can improve their ability to do daily tasks, reduce fatigue, and boost exercise capacity. Seventy patients with advanced COPD will be randomly assigned to receive this training or standard care. The goal is to see if these simple strategies help patients stay active with less shortness of breath.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
structured energy conservation techniques training
What this could lead to
If it works, this training could help COPD patients manage fatigue and breathe easier during daily tasks, improving their quality of life.
What could go wrong
This is a small, early-stage trial with only 70 participants and no blinding. The training may not provide significant benefits over standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 70 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients who have been admitted to the pulmonary diseases ward or have applied to the pulmonary diseases outpatient clinic, * Patients diagnosed with COPD, * Patients in category E of the GOLD A, B, E classification (patients experiencing more than 2 moderate exacerbations or having multiple hospitalizations) (GOLD, 2025) * Patients over 40 years of age (Adeloye et al, 2015). * Patients who will continue their health check-ups at the Isparta City Hospital Pulmonology Outpatient Clinic, * Patients who agree to participate in the study, * Patients or at least one of their relatives who can read and write, * Patients or at least one of their relatives who does not have communication problems will be included in the study. Exclusion Criteria: * Patients with serious orthopedic problems that may have a significant impact on daily activities, * Patients with progressive neuromuscular disease, * Patients who have experienced unstable angina pectoris or myocardial infarction within the last month, * Patients living alone, * Patients in groups A and B of the GOLD ABE classification will not be included. For patients in group A, mMRC 0-1, CAT\<10 are used as criteria; for patients in group B, mMRC≥2, CAT≥10 are used as criteria (GOLD, 2025).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic obstructive pulmonary disease (COPD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic obstructive pulmonary disease (COPD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Isparta Şehir Hastanesi

    Isparta, Isparta, 32040, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.